Metamizol Normon

Metamizole magnesium, the active ingredient in Metamizol Normon, is a pyrazolone analgesic presented as a standard dosage form for intramuscular, intravenous, and oral use. It treats acute pain, postoperative pain, fever and colic in adult patients.

GNH USA supplies Metamizol Normon as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metamizole magnesium is used to manage pain and fever through inhibition of cyclooxygenase enzymes and modulation of pain pathways.

Acute pain: provides rapid analgesia for sudden severe pain. Post‑operative pain: reduces discomfort after surgical procedures. Fever: lowers elevated body temperature. Colic: alleviates visceral pain associated with colic episodes.

Metamizole magnesium may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea or vomiting - Dizziness or light‑headedness - Transient hypotension - Injection‑site pain or irritation - Mild skin rash - Headache

Serious or Rare Side Effects: - Agranulocytosis (dangerously low white‑blood‑cell count) - Severe allergic reactions such as anaphylaxis - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Significant liver enzyme elevations - Blood dyscrasias including thrombocytopenia - Life‑threatening hypotension

Metamizole magnesium requires careful patient assessment and monitoring.

Assess renal and hepatic function before initiating therapy. Monitor complete blood count regularly, especially during early treatment. Use with caution in patients with known hypersensitivity to pyrazolones. Avoid in individuals with a history of agranulocytosis or severe blood dyscrasias. Adjust dosing in elderly patients or those with compromised organ function. Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Metamizole magnesium can interact with several drug classes, necessitating vigilance.

Major Interactions (Avoid): - Concurrent myelosuppressive agents (e.g., chemotherapy) – increased risk of severe blood cell suppression. - Anticoagulants (e.g., warfarin) – heightened bleeding tendency. - ACE inhibitors or other antihypertensives – additive hypotensive effect.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs – combined gastrointestinal irritation. - Diuretics – potential for enhanced hypotension. - Lithium – possible alteration of lithium serum levels.